Glenmark Pharmaceuticals (NSE:GLENMARK) Margin of Safety % (DCF FCF Based): -24.06% (As of Jun. 30, 2026)


NSE:GLENMARK Glenmark Pharmaceuticals Ltd NSE:GLENMARK
86 GF Score
Price ₹2,186.60
GF Value ₹1,988.54
Valuation Fairly Valued
View Full Analysis

What is Glenmark Pharmaceuticals Margin of Safety % (DCF FCF Based)?

Glenmark Pharmaceuticals NSE:GLENMARK +1.49% 86 Margin of Safety % (DCF FCF Based) is -24.06% as of Jun. 30, 2026. GuruFocus rates NSE:GLENMARK with a GF Score™ of 86/100 and a GF Value™ of ₹1,988.54 (Fairly Valued).

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-30), Glenmark Pharmaceuticals's Predictability Rank is 1.5-Stars. Glenmark Pharmaceuticals's intrinsic value calculated from the Discounted FCF model is ₹2441.56 and current share price is ₹2186.60. Consequently,

Glenmark Pharmaceuticals's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -24.06%.

NSE:GLENMARK vs ZTS, UTHR: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Pharmaceuticals's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Glenmark Pharmaceuticals Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glenmark Pharmaceuticals's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Glenmark Pharmaceuticals's Margin of Safety % (DCF FCF Based) falls into.


NSE:GLENMARK
86GF Score
Glenmark Pharmaceuticals Ltd NSE:GLENMARK
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Glenmark Pharmaceuticals Margin of Safety % (DCF FCF Based) Calculation

Glenmark Pharmaceuticals's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(1762.53-2186.60)/1762.53
=-24.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

What does a Margin of Safety % (DCF FCF Based) of -24.06% mean?
Glenmark Pharmaceuticals (NSE:GLENMARK) has a Margin of Safety % (DCF FCF Based) of -24.06% as of Jun. 30, 2026. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on Glenmark Pharmaceuticals.
Is Glenmark Pharmaceuticals' Margin of Safety % (DCF FCF Based) too high?
Glenmark Pharmaceuticals' current Margin of Safety % (DCF FCF Based) is -24.06%. Overall, Glenmark Pharmaceuticals has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Glenmark Pharmaceuticals' Margin of Safety % (DCF FCF Based) compare to ZTS and UTHR?
Glenmark Pharmaceuticals' Margin of Safety % (DCF FCF Based) of -24.06% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF FCF Based) for a Drug Manufacturers company?
A good Margin of Safety % (DCF FCF Based) depends on the Drug Manufacturers industry context. However, Margin of Safety % (DCF FCF Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF FCF Based) mean?
A high Margin of Safety % (DCF FCF Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on Glenmark Pharmaceuticals. Glenmark Pharmaceuticals's current Margin of Safety % (DCF FCF Based) is -24.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glenmark Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Glenmark Pharmaceuticals (NSE:GLENMARK) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,988.54, compared to a current price of ₹2,186.60 — trading 10% above its estimated fair value. The current Margin of Safety % (DCF FCF Based) is -24.06%. Glenmark Pharmaceuticals' overall GF Score™ is 86/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF FCF Based) calculated?
Margin of Safety % (DCF FCF Based) is calculated from a company's financial statements. For Glenmark Pharmaceuticals (NSE:GLENMARK), the current Margin of Safety % (DCF FCF Based) is -24.06% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Glenmark Pharmaceuticals (NSE:GLENMARK) Overvalued in 2026?

Based on GuruFocus' analysis, Glenmark Pharmaceuticals stock appears to be overvalued. The current stock price of ₹2,186.60 is trading 10% above its estimated GF Value™ of ₹1,988.54. GuruFocus considers Glenmark Pharmaceuticals to be Fairly Valued.

Key valuation signals for NSE:GLENMARK:

  • Margin of Safety % (DCF FCF Based): -24.06%
  • GF Value™: ₹1,988.54 vs. price of ₹2,186.60 (10% above fair value)
  • GF Score™: 86/100

No single metric tells the full story. See the NSE:GLENMARK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Glenmark Pharmaceuticals Business Description

Other Exchanges 532296:India
Address B. D. Sawant Marg, Glenmark House, Chakala, Off Western Express Highway, Andheri (East), Mumbai, MH, IND, 400099
Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities. It has a business presence in different therapeutic areas such as dermatology, respiratory, oncology, diabetes, cardiovascular, and oral contraceptives among others. Geographically, it derives key revenue from India and the rest from North America, Latin America, Europe and the Rest of the world.
86GF Score

Get the complete analysis for NSE:GLENMARK

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,186.60
Price
₹1,988.54
GF Value